Novo Nordisk's pricing approaches within the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of cost gouging, stating the stark distinction amongst U.S. prices and those in Europe and copyright.This led Novo Nordisk to carry out even further research into bigger dosages of semaglutide specifically f